Treatment satisfaction with ITCA 650, a novel drug‐device delivering continuous exenatide, versus twice‐daily injections of exenatide in type 2 diabetics using metformin
Robert Henry; Julio Rosenstock; John F. McCarthy; Ginger Carls; Tom Alessi; John Yee; Michelle Baron
Author Information: Division of Endocrinology and Metabolism, Department of Medicine
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.